The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksElementis Regulatory News (ELM)

Share Price Information for Elementis (ELM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 147.80
Bid: 147.00
Ask: 147.80
Change: 2.00 (1.37%)
Spread: 0.80 (0.544%)
Open: 144.00
High: 147.80
Low: 144.00
Prev. Close: 145.80
ELM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Q3 Trading Update

31 Oct 2019 07:00

RNS Number : 6889R
Elementis PLC
31 October 2019
 

Elementis plc

Q3 Trading Update

Delivering further performance in 2019, broadly in line with expectations

Solid overall trading in Personal Care, Coatings & Talc

Elementis plc ("Elementis" or the "Group"), a global specialty chemicals company, today issues a trading update for the three months ended 30 September 2019.

Whilst the slowdown in broader macroeconomic conditions continues, self-help actions are anticipated to result in an improved second half performance, broadly in line with expectations. The Group's strong free cash generation continued in Q3.

The Talc integration is now complete with functional teams embedded and delivery of synergies on track. The Group remains focused on executing its plans to transform Coatings, grow Personal Care and expand Talc. This strategy, supported by self-help measures focused on cost efficiency and cash delivery will provide a robust financial platform to deliver future growth and shareholder value creation.

Business performance

·; Personal Care had a steady third quarter with solid performance in cosmetics and further sequential volume improvement in anti-perspirant actives, with margins impacted by tariffs. We continue to make progress on new product launches targeting the skin care market.

 

·; In Coatings, demand conditions were in line with expectations. Whilst activity modestly improved in the North American and Asian architectural markets, industrial coatings demand remained sluggish across all geographies. Margins were resilient supported by cost savings, new product launches and price/mix improvements.

 

·; In Talc performance was in line with expectations with strong demand for high value industrial applications such as technical ceramics and coatings, offsetting weak plastics. A much improved second half performance continues to be expected driven by new business, cost synergies and nickel sales phasing.

 

·; Whilst Energy is a small part of Elementis, performance was weaker than expected due to a further slowdown in North American drilling activity. As a result, second half performance is anticipated to significantly decline on the first six months.

 

·; In Chromium, pricing in our rest of the world operations further weakened, reflecting lower global industry capacity utilisation and increased competitive intensity. Performance in North America, where our operations enjoy significant structural advantages, has remained relatively robust. As a result, performance in the second half is anticipated to be broadly in line with the first six months of 2019.

 

Commenting on the performance, CEO, Paul Waterman said,

"Whilst market conditions remain challenging, overall performance in Personal Care, Coatings and Talc has been in line with expectations due to our self-help actions. Although there are no signs of improvement in global economic conditions, the fundamentals of our business remain strong. We are confident about our significant medium term innovation, growth and efficiency opportunities. This will be the focus of our Capital Markets Day in November."

Enquiries

Elementis plc

James Curran, Investor Relations Tel: 020 7067 2994

 

Tulchan

Martin Robinson Tel: 020 7353 4200

David Allchurch

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTURRNRKKAROAA
Date   Source Headline
8th May 202411:08 amRNSDirector/PDMR Shareholding
3rd May 202411:46 amRNSHolding(s) in Company
1st May 202410:06 amRNSTotal Voting Rights
30th Apr 202411:36 amRNSResult of AGM
30th Apr 20247:00 amRNSFirst quarter trading update
29th Apr 202412:13 pmRNSResponse to open letter from Gatemore
12th Apr 202411:33 amRNSDirector/PDMR Shareholding
12th Apr 202411:28 amRNSDirector/PDMR Shareholding
9th Apr 20246:04 pmRNSDirector/PDMR Shareholding
26th Mar 20244:07 pmRNSAnnual Financial Report & Notice of AGM
19th Mar 20243:02 pmRNSAdditional Listing
15th Mar 20241:00 pmRNSDirectorate Change
12th Mar 20244:38 pmRNSDirector/PDMR Shareholding
12th Mar 20244:33 pmRNSDirector/PDMR Shareholding
8th Mar 20245:56 pmRNSDirector/PDMR Shareholding
7th Mar 20247:00 amRNSDirectorate changes
7th Mar 20247:00 amRNSPreliminary results year ended 31 December 2023
1st Mar 20249:30 amRNSBlock listing Interim Review
18th Jan 20247:00 amRNSTrading Update
2nd Jan 20249:45 amRNSTotal Voting Rights
1st Dec 202310:46 amRNSTotal Voting Rights
30th Nov 20239:38 amRNSDirector/PDMR Shareholding
14th Nov 20237:00 amRNS2023 Capital Markets Day
1st Nov 20239:46 amRNSTotal Voting Rights
31st Oct 20237:00 amRNSThird Quarter Trading Update
2nd Oct 20239:34 amRNSTotal Voting Rights
20th Sep 202312:09 pmRNSResponse to open letter from Franklin Templeton
12th Sep 20233:13 pmRNSDirector Declaration
8th Sep 20239:30 amRNSHolding(s) in Company
1st Sep 20239:49 amRNSBlock listing Interim Review
1st Sep 20239:42 amRNSTotal Voting Rights
1st Aug 20239:44 amRNSTotal Voting Rights
27th Jul 20232:16 pmRNSHolding(s) in Company
27th Jul 20237:00 amRNSHalf-year Report
20th Jul 202312:58 pmRNSHolding(s) in Company
3rd Jul 202310:21 amRNSTotal Voting Rights
29th Jun 20234:29 pmRNSDirector/PDMR Shareholding
23rd Jun 20239:32 amRNSDirector/PDMR Shareholding
30th May 20238:06 amRNSDirector Declaration
2nd May 20239:37 amRNSTotal Voting Rights
26th Apr 20232:12 pmRNSResult of AGM
26th Apr 20237:00 amRNSAGM Trading Statement
17th Apr 202310:15 amRNSDirector/PDMR Shareholding
17th Apr 202310:10 amRNSDirector/PDMR Shareholding
13th Apr 20234:24 pmRNSDirector/PDMR Shareholding
3rd Apr 202311:28 amRNSDirector Declaration
3rd Apr 20239:34 amRNSTotal Voting Rights
24th Mar 20239:27 amRNSDirector/PDMR Shareholding
22nd Mar 20234:02 pmRNSAnnual Financial Report & Notice of AGM
17th Mar 20232:58 pmRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.